Association between RANTES promoter polymorphism −401A and enhanced RANTES production in atopic dermatitis patients
Authors:
- Hisashi SugiuraHSHisashi Sugiura
- 1 September 2005
- journal article
- other
- Published by Elsevier in Journal of Dermatological Science
- Vol. 39 (3) , 189-191
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitisClinical and Experimental Immunology, 2004
- Steroid and Antihistamines Modulate Rantes Release in Cultured Peripheral Blood Mononuclear Cells of Atopic PatientsInternational Journal of Immunopathology and Pharmacology, 2002
- Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitisArchives of Dermatological Research, 2001
- The C–C chemokines, RANTES and eotaxin, in atopic dermatitisAllergy, 2001
- The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthmaGenes & Immunity, 2000
- Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTESThe Journal of Immunology, 2000
- Correlation between Protein and mRNA Abundance in YeastMolecular and Cellular Biology, 1999
- Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES proteinEuropean Journal of Immunology, 1996
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993